| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8969250 | Tuberculosis | 2005 | 12 Pages |
Abstract
Conclusions: This study showed that rBCG38 vaccine induced a strong Th1 response, demonstrated by the high levels of IL-2 and IFN-γ producer cells and IgG2a. Protection was mediated for as long as 6 and 4 months after challenge with M. tuberculosis H37Rv and Beijing genotypes, respectively.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mauricio Castañon-Arreola, Yolanda López-Vidal, Clara Espitia-Pinzón, Rogelio Hernández-Pando,